Clinical Trial Update: IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the combination of IRESSA (Gefitinib) with cisplatin and radiotherapy in previously untreated, unresected late-stage III/IV non-metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Iressa (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Neoplasms, Squamous Cell | Phase 2 | Status: COMPLETED | Results posted: 2009-08-04